Advertisement
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 11 to 15

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Opioid-related deaths in the cancer population are much rarer than in the general population

Opioid-Related Deaths Less Likely Among Cancer Patients

0
Mortality lower despite common opioid prescriptions for cancer-related pain
In a joint guidance document issued by the American Society for Bone and Mineral Research

Guidance Issued for Osteoporosis Management During COVID-19

0
Alternative methods for parenteral treatments include off-site clinics, home visit, self-injection
Regular aspirin use is associated with a lower risk for colorectal and other digestive tract cancers

Regular Aspirin Use Tied to Lower Risk for Digestive Tract Cancers

0
Favorable effect increases with longer duration of use, and, for colorectal cancer, with increasing dose
For patients undergoing elective surgery

Graduated Compression Stockings May Not Be Needed After Surgery

0
Low molecular weight heparin noninferior to LMWH plus GCS for preventing VTE after elective surgery
In a personal view article

Experts Discuss Strategy for Bariatric Surgery During COVID-19

0
Recommendations address nonsurgical management, prioritization of patients once surgery resumes
For hospitalized patients with COVID-19

Addition of Zinc May Benefit Some Being Treated for COVID-19

0
Some outcomes improved with addition of zinc sulfate to hydroxychloroquine and azithromycin
A deal for hundreds of millions of syringes that could be used to quickly administer a possible vaccine against COVID-19 has been reached between the U.S. government and a private company.

Plan in Place to Up Production of Prefilled Syringes for Future COVID-19 Vaccine

0
Project Jumpstart aims to produce 100 million prefilled syringes by the end of 2020 and more than 500 million in 2021
Atezolizumab plus bevacizumab improves survival outcomes versus sorafenib in patients with unresectable hepatocellular carcinoma

Atezolizumab-Bevacizumab Beats Sorafenib in Liver Cancer

0
Overall, progression-free survival longer with combo in unresectable hepatocellular carcinoma
For women with bacterial vaginosis

Live Biotherapeutic Promising for Prevention of Bacterial Vaginosis

0
Following vaginal metronidazole for BV, incidence of recurrence lower with Lactin-V versus placebo